NCT04373551View on ClinicalTrials.gov

WeExPAnd: PrEP Demonstration Project Among Women At Risk for HIV Infection - Preexposure Prophylaxis (PrEP)

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
HIV-infection/AIDS
Interventions
BEHAVIORAL

Cultural adaptation of a patient-provider communication tool

Adaptation of a patient-provider communication tool for PrEP uptake utilized among AA women and their providers in a pilot pre/post-intervention design.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT04373551 - WeExPAnd: PrEP Demonstration Project Among Women At Risk for HIV Infection - Preexposure Prophylaxis (PrEP) | Biotech Hunter | Biotech Hunter